Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902
- PMID: 24910380
- PMCID: PMC4163109
- DOI: 10.1016/j.bbmt.2014.05.027
Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902
Abstract
Studies show that engaging patients in exercise and/or stress management techniques during hematopoietic cell transplantation (HCT) improves quality of life. The Blood and Marrow Transplant Clinical Trials Network tested the efficacy of training patients to engage in self-directed exercise and stress management during HCT. The study randomized 711 patients at 21 centers to receive 1 of 4 training interventions before HCT: a self-directed exercise program, a self-administered stress management program, both, or neither. Participants completed self-reported assessments at enrollment and up to 180 days after HCT. Randomization was stratified by center and transplant type. There were no differences in the primary endpoints of the Physical Component Summary and Mental Component Summary scales of the Medical Outcomes Study Short Form 36 at day +100 among the groups, based on an intention-to-treat analysis. There also were no differences in overall survival, days of hospitalization through day +100 post-HCT, or in other patient-reported outcomes, including treatment-related distress, sleep quality, pain, and nausea. Patients randomized to training in stress management reported more use of those techniques, but patients randomized to training in exercise did not report more physical activity. Although other studies have reported efficacy of more intensive interventions, brief training in an easy-to-disseminate format for either self-directed exercise or stress management was not effective in our trial.
Keywords: Allogeneic hematopoietic cell transplantation; Autologous hematopoietic cell transplantation; Exercise; Quality of life; Stress management.
Copyright © 2014 American Society for Blood and Marrow Transplantation. All rights reserved.
Conflict of interest statement
The authors declare no competing financial interests related to this study.
Similar articles
-
Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).Cancer. 2016 Jan 1;122(1):91-8. doi: 10.1002/cncr.29717. Epub 2015 Oct 6. Cancer. 2016. PMID: 26439325 Free PMC article. Clinical Trial.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
Admission of hematopoietic cell transplantation patients to the intensive care unit at the Pontificia Universidad Católica de Chile Hospital.Biol Blood Marrow Transplant. 2015 Jan;21(1):176-9. doi: 10.1016/j.bbmt.2014.08.009. Epub 2014 Aug 17. Biol Blood Marrow Transplant. 2015. PMID: 25139214
-
Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).Biol Blood Marrow Transplant. 2019 Nov;25(11):2143-2151. doi: 10.1016/j.bbmt.2019.06.029. Epub 2019 Jul 2. Biol Blood Marrow Transplant. 2019. PMID: 31271885 Free PMC article. Clinical Trial.
-
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.Biol Blood Marrow Transplant. 2015 Jul;21(7):1155-66. doi: 10.1016/j.bbmt.2015.03.002. Epub 2015 Mar 11. Biol Blood Marrow Transplant. 2015. PMID: 25769794 Review.
Cited by
-
Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant. 2018 Jun;24(6):1111-1118. doi: 10.1016/j.bbmt.2018.01.029. Epub 2018 Feb 3. Biol Blood Marrow Transplant. 2018. PMID: 29408289 Free PMC article.
-
Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial.Biol Blood Marrow Transplant. 2016 Dec;22(12):2256-2263. doi: 10.1016/j.bbmt.2016.08.016. Epub 2016 Aug 23. Biol Blood Marrow Transplant. 2016. PMID: 27565521 Free PMC article. Clinical Trial.
-
The Transplant Evaluation Rating Scale predicts overall survival after allogeneic hematopoietic stem cell transplantation.Blood Adv. 2020 Oct 13;4(19):4812-4821. doi: 10.1182/bloodadvances.2020002204. Blood Adv. 2020. PMID: 33022065 Free PMC article.
-
Personalized home-based interval exercise training may improve cardiorespiratory fitness in cancer patients preparing to undergo hematopoietic cell transplantation.Bone Marrow Transplant. 2016 Jul;51(7):967-72. doi: 10.1038/bmt.2016.73. Epub 2016 Mar 21. Bone Marrow Transplant. 2016. PMID: 26999467 Free PMC article.
-
Patient perspectives on physical function after allogeneic hematopoietic stem cell transplantation: a qualitative study.Bone Marrow Transplant. 2017 Oct;52(10):1483-1484. doi: 10.1038/bmt.2017.176. Epub 2017 Aug 7. Bone Marrow Transplant. 2017. PMID: 28783149 Clinical Trial. No abstract available.
References
-
- Bush NE, Donaldson GW, Haberman MH, Dacanay R, Sullivan KM. Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol Blood Marrow Transplant. 2000;6(5A):576–591. - PubMed
-
- Gruber U, Fegg M, Buchmann M, Kolb HJ, Hiddemann W. The long-term psychosocial effects of haematopoetic stem cell transplantation. Eur J Cancer Care (Engl) 2003;12(3):249–256. - PubMed
-
- Lee SJ, Fairclough D, Parsons SK, et al. Recovery after stem-cell transplantation for hematologic diseases. J Clin Oncol. 2001;19(1):242–252. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U10 HL069294/HL/NHLBI NIH HHS/United States
- U10 HL109526/HL/NHLBI NIH HHS/United States
- U01 HL069246/HL/NHLBI NIH HHS/United States
- U24 CA076518/CA/NCI NIH HHS/United States
- U10 HL069301/HL/NHLBI NIH HHS/United States
- U10 HL069330/HL/NHLBI NIH HHS/United States
- U10 HL069310/HL/NHLBI NIH HHS/United States
- U10 HL109137/HL/NHLBI NIH HHS/United States
- U10HL069294/HL/NHLBI NIH HHS/United States
- R01 CA160684/CA/NCI NIH HHS/United States
- U10 HL109322/HL/NHLBI NIH HHS/United States
- U10 HL108945/HL/NHLBI NIH HHS/United States
- U10 HL069246/HL/NHLBI NIH HHS/United States
- U10 HL108987/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical